{"id":"https://openalex.org/G1925138688","display_name":"EphA2 mediates opening of the blood brain barrier in cerebral malaria","description":"The proposed research is relevant to public health because EphA2 is a completely novel target for an adjunc- tive therapy to limit breakdown of the blood brain barrier - a key event in cerebral malaria. This in turn has the potential to save the lives of >0.5 million children with life-threatening symptoms of this condition every year. Thus, the proposed research is relevant to the part of the NIH's mission that pertains to developing fundamen- tal knowledge that will help to reduce the burdens of human disease and disability.","funder_award_id":"R01NS097819","funder":{"id":"https://openalex.org/F4320337359","display_name":"National Institute of Neurological Disorders and Stroke","doi":"https://doi.org/10.13039/100000065"},"funded_outputs":["https://openalex.org/W2949592035","https://openalex.org/W2954291228","https://openalex.org/W2993967899","https://openalex.org/W3004219543","https://openalex.org/W4295941972"],"funded_outputs_count":5,"parent_awards":[],"sub_awards":[{"funder":{"display_name":"University of Utah","id":"https://openalex.org/F4320310050"},"asserted_by":"funder","relationship":"sub_award","display_name":"EphA2 mediates opening of the blood brain barrier in cerebral malaria (sub-award to EMORY UNIVERSITY)","id":"https://openalex.org/G9001183180"},{"funder":{"display_name":"University of Utah","id":"https://openalex.org/F4320310050"},"asserted_by":"funder","relationship":"sub_award","display_name":"EphA2 mediates opening of the blood brain barrier in cerebral malaria (sub-award to CENTRE PASTEUR DU CAMEROUN)","id":"https://openalex.org/G9001287214"}],"sub_awards_count":2,"amount":null,"currency":"USD","amount_usd":null,"amount_usd_basis":null,"recipients":[],"recipient_countries":[],"recipient_regions":[],"research_scope":{"is_research":true,"basis":"funder_default","tier":1},"funding_type":"research","funder_scheme":"R01","start_date":"2017-03-01","end_date":"2023-02-28","start_year":2017,"end_year":2023,"landing_page_url":"https://reporter.nih.gov/project-details/10111575","doi":null,"provenance":"nih_exporter","lead_investigator":{"given_name":"TRACEY JANE","family_name":"LAMB","orcid":null,"role_start":null,"affiliation":{"name":"UNIVERSITY OF UTAH","country":"UNITED STATES","ids":null},"author":{"id":"https://openalex.org/A5030344106","display_name":"Tracey J. Lamb","orcid":"https://orcid.org/0000-0003-0620-3944"},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}]},"co_lead_investigator":null,"investigators":null,"works_api_url":"https://api.openalex.org/works?filter=awards.id:G1925138688","primary_topic":{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.5303,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.5303,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10091","display_name":"Malaria Research and Control","score":0.3982,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12061","display_name":"Axon Guidance and Neuronal Signaling","score":0.0034,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epha2","display_name":"EphA2","score":0.979},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.835},{"id":"https://openalex.org/keywords/cerebral-malaria","display_name":"cerebral malaria","score":0.987},{"id":"https://openalex.org/keywords/blood-brain-barrier-permeability","display_name":"blood-brain barrier permeability","score":0.697},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.858},{"id":"https://openalex.org/keywords/plasmodium-falciparum","display_name":"Plasmodium falciparum","score":0.895},{"id":"https://openalex.org/keywords/pediatric-malaria","display_name":"pediatric malaria","score":0.506},{"id":"https://openalex.org/keywords/receptor-signaling","display_name":"receptor signaling","score":0.463}],"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"institution_awarded":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]}],"updated_date":"2026-11-13T03:01:57.000Z","created_date":"2026-10-09T19:56:01.000Z"}
